[Effect of therapeutic doses of CIBA 32644-Ba on hematopoiesis in patients affected with bilharziasis and amebiasis].
D000328:Adult; D000562:Amebiasis / Q000188:drug therapy*; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D001669:Biochemical Phenomena; D001671:Biochemistry; D003223:Congo; D004912:Erythrocytes / Q000201:enzymology; D005955:Glucosephosphate Dehydrogenase Deficiency; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D012552:Schistosomiasis / Q000188:drug therapy*; D013053:Spectrophotometry
D000871:Anthelmintics
Influence des doses thérapeutiques du CIBA 32644-Ba sur l'hématopoïèse des patients atteints de bilharziose et d'amibiase.